Success Stories: EB-1A Approved: NAILG Helps Postdoctoral Researcher in Pharmaceutical Sciences Achieve Success in Only 18 Days (Premium Processing)

 

Client’s Testimonial:

“Thank you very much for your warm message and for all the outstanding support during my I-140 EB1A petition process. I am truly grateful for your expertise, responsiveness, and professionalism throughout this important stage of my journey. I would like to extend a special thank-you to Ziqian M., who worked tirelessly and was incredibly supportive from start to finish. Ziqian’s guidance, attention to detail, and patience were deeply appreciated and made a meaningful difference in my experience. Thank you once again for your excellent service. I would be glad to recommend your firm to friends and colleagues seeking immigration support.”


On April 24th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Researcher in the Field of Pharmaceutical Sciences (Approval Notice).


General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: India

State of Residence at the Time of Filing: North Carolina

Approval Notice Date: April 24th, 2025

Processing Time: 18 days (Premium Processing Requested)


Case Summary:

The North America Immigration Law Group (NAILG) recently celebrated the EB-1A approval of a remarkable pharmaceutical sciences researcher whose work contributes significantly to advancing the understanding and treatment of chronic diseases. With a specialized focus on pharmacology, toxicology, pharmacodynamics, and drug development, our client has become a respected leader in developing innovative therapeutics and analyzing the global burden of major health conditions.

To advance his career and continue his vital research in the United States, the client engaged North America Immigration Law Group (NAILG) for assistance with an EB-1A (Alien of Extraordinary Ability) petition. Our team conducted a thorough review of his academic achievements, research accomplishments, and the significance of his ongoing work. We then crafted a comprehensive petition that underscored both his scientific leadership and the lasting impact of his contributions to the field.

To support the petition, NAILG presented multiple lines of evidence demonstrating his outstanding achievements:

➢ Authorship of 52 peer-reviewed journal articles, 1 accepted journal article.
➢ His research has earned 7,116 citations, placing him in the top 1% of highly cited authors in pharmaceutical sciences over the past decade.
➢ A proven record of peer recognition through more than 200 reviews for prestigious scientific journals, including several top-ranked publications in his field.
➢ Editorial board service for influential journals, reflecting his leadership and expertise in evaluating cutting-edge research.
➢ His work has been supported by major funding agencies at both international and national levels.

His research has not only generated new scientific knowledge but has also been directly applied by experts worldwide to develop treatments for chronic kidney disease, neurological disorders, and cancer. Notably, at least 21 of his papers rank among the most highly cited in pharmacology and toxicology for their publication years, underscoring their substantial impact.

As one expert recommender emphasized:

“[Client]’s research directly addresses two of the most pressing public health challenges in the United States: diabetes and neurological disorders. His work provides critical insights into the global prevalence and risk factors associated with these conditions, enabling the development of targeted prevention and management strategies that alleviate the strain on the U.S. healthcare system. By using advanced statistical models and the GBD framework, [client]’s findings are instrumental in informing national health initiatives, such as the National Diabetes Prevention Program by the Centers for Disease Control and Prevention. His research helps shape public health policies for both metabolic and neurological care, optimizing resource allocation and improving healthcare delivery. Furthermore, his work on diabetes, particularly the link between obesity, type 2 diabetes, and neurological complications, has direct relevance for reducing healthcare costs and improving the quality of life for millions of Americans, particularly in underserved communities.”

Ultimately, our team demonstrated that the client has earned national and international acclaim and that his future research in the United States will continue to advance scientific discovery and improve public health outcomes. We are proud to have supported such a distinguished researcher in securing EB-1A classification and look forward to the continued impact his work will have on the global pharmaceutical landscape.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.


approval_table_2017

Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation: https://www.wegreened.com/Free-Evaluation

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.